vs
Side-by-side financial comparison of Healthpeak Properties (DOC) and Ventas (VTR), based on the latest 10-Q / 10-K filings. Click either name above to swap in a different company.
Ventas is the larger business by last-quarter revenue ($1.6B vs $155.7M, roughly 10.1× Healthpeak Properties). Healthpeak Properties runs the higher net margin — 73.2% vs 4.7%, a 68.5% gap on every dollar of revenue. On growth, Ventas posted the faster year-over-year revenue change (21.7% vs 6.7%). Over the past eight quarters, Ventas's revenue compounded faster (14.2% CAGR vs 5.9%).
Healthpeak Properties, Inc. is an American real estate investment trust that invests in real estate related to the healthcare industry including senior housing, life science, and medical offices. It was organized in 2007 in Maryland and headquartered in Denver, Colorado with offices in Irvine, Nashville and San Francisco. As of December 31, 2019, the company owned interests in 617 properties.
Ventas may refer to:Ventas (company), a real estate investment trust (REIT), invests primarily in real estate serving the United States healthcare industry Ventas (Madrid), a ward (barrio) of Madrid, Spain belonging to the district of Ciudad Lineal Ventas, a station on Line 2 and 5 Ventas de Zafarraya, a village in Grenada, Spain
DOC vs VTR — Head-to-Head
Income Statement — Q4 2025 vs Q4 2025
| Metric | | |
|---|---|---|
| Revenue | $155.7M | $1.6B |
| Net Profit | $114.0M | $73.0M |
| Gross Margin | — | — |
| Operating Margin | 80.3% | 4.9% |
| Net Margin | 73.2% | 4.7% |
| Revenue YoY | 6.7% | 21.7% |
| Net Profit YoY | 2406.4% | 24.3% |
| EPS (diluted) | $0.16 | $0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align — see 8-quarter trend below.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history — bar widths are scaled to the larger of the two companies so you can eyeball the size gap and growth trajectory without doing math. Quarters aligned by calendar period (report date) so offset fiscal years line up.
| Q4 25 | $155.7M | $1.6B | ||
| Q3 25 | $150.5M | $1.5B | ||
| Q2 25 | $148.9M | $1.4B | ||
| Q1 25 | $148.9M | $1.4B | ||
| Q4 24 | $146.0M | $1.3B | ||
| Q3 24 | $142.8M | $1.2B | ||
| Q2 24 | $140.9M | $1.2B | ||
| Q1 24 | $138.8M | $1.2B |
| Q4 25 | $114.0M | $73.0M | ||
| Q3 25 | $-117.1M | $68.7M | ||
| Q2 25 | $31.7M | $71.5M | ||
| Q1 25 | $42.8M | $48.4M | ||
| Q4 24 | $4.5M | $58.7M | ||
| Q3 24 | $85.9M | $21.0M | ||
| Q2 24 | $146.0M | $21.2M | ||
| Q1 24 | $6.7M | $-12.5M |
| Q4 25 | — | — | ||
| Q3 25 | -94.0% | — | ||
| Q2 25 | -85.5% | — | ||
| Q1 25 | -83.4% | — | ||
| Q4 24 | -89.8% | — | ||
| Q3 24 | -96.2% | — | ||
| Q2 24 | -94.4% | — | ||
| Q1 24 | -75.6% | — |
| Q4 25 | 80.3% | 4.9% | ||
| Q3 25 | 43.4% | 3.0% | ||
| Q2 25 | 26.6% | 3.0% | ||
| Q1 25 | 36.5% | 3.0% | ||
| Q4 24 | -2.2% | -0.0% | ||
| Q3 24 | 69.0% | 1.5% | ||
| Q2 24 | — | -1.6% | ||
| Q1 24 | 16.2% | -0.6% |
| Q4 25 | 73.2% | 4.7% | ||
| Q3 25 | -77.8% | 4.6% | ||
| Q2 25 | 21.3% | 5.0% | ||
| Q1 25 | 28.8% | 3.6% | ||
| Q4 24 | 3.1% | 4.6% | ||
| Q3 24 | 60.1% | 1.7% | ||
| Q2 24 | 103.7% | 1.8% | ||
| Q1 24 | 4.8% | -1.0% |
| Q4 25 | $0.16 | $0.15 | ||
| Q3 25 | $-0.17 | $0.14 | ||
| Q2 25 | $0.05 | $0.15 | ||
| Q1 25 | $0.06 | $0.10 | ||
| Q4 24 | $0.02 | $0.13 | ||
| Q3 24 | $0.12 | $0.05 | ||
| Q2 24 | $0.21 | $0.05 | ||
| Q1 24 | $0.01 | $-0.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest filing — the kind of financial-strength check premium terminals charge for.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $467.5M | $741.1M |
| Total DebtLower is stronger | $9.8B | $13.0B |
| Stockholders' EquityBook value | $7.5B | $12.5B |
| Total Assets | $20.3B | $27.6B |
| Debt / EquityLower = less leverage | 1.31× | 1.04× |
8-quarter trend — quarters aligned by calendar period so offset fiscal years match up.
| Q4 25 | $467.5M | $741.1M | ||
| Q3 25 | $91.0M | $188.6M | ||
| Q2 25 | $89.4M | $614.2M | ||
| Q1 25 | $70.6M | $182.3M | ||
| Q4 24 | $119.8M | $897.9M | ||
| Q3 24 | $180.4M | $1.1B | ||
| Q2 24 | $106.9M | $557.1M | ||
| Q1 24 | $101.8M | $632.4M |
| Q4 25 | $9.8B | $13.0B | ||
| Q3 25 | $9.1B | — | ||
| Q2 25 | $9.0B | — | ||
| Q1 25 | $8.9B | — | ||
| Q4 24 | $8.7B | $13.5B | ||
| Q3 24 | $8.6B | — | ||
| Q2 24 | $8.6B | — | ||
| Q1 24 | $8.8B | — |
| Q4 25 | $7.5B | $12.5B | ||
| Q3 25 | $7.6B | $12.4B | ||
| Q2 25 | $7.9B | $11.5B | ||
| Q1 25 | $8.2B | $11.5B | ||
| Q4 24 | $8.4B | $10.8B | ||
| Q3 24 | $8.6B | $9.8B | ||
| Q2 24 | $8.8B | $9.6B | ||
| Q1 24 | $8.9B | $9.4B |
| Q4 25 | $20.3B | $27.6B | ||
| Q3 25 | $19.6B | $26.9B | ||
| Q2 25 | $19.8B | $26.5B | ||
| Q1 25 | $19.8B | $26.0B | ||
| Q4 24 | $19.9B | $26.2B | ||
| Q3 24 | $20.0B | $25.3B | ||
| Q2 24 | $20.2B | $24.5B | ||
| Q1 24 | $20.5B | $24.7B |
| Q4 25 | 1.31× | 1.04× | ||
| Q3 25 | 1.20× | — | ||
| Q2 25 | 1.14× | — | ||
| Q1 25 | 1.08× | — | ||
| Q4 24 | 1.04× | 1.26× | ||
| Q3 24 | 1.00× | — | ||
| Q2 24 | 0.98× | — | ||
| Q1 24 | 0.99× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Net income can be massaged; cash flow is harder to fake.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $294.1M | $471.7M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue; lower = less reinvestment burden | — | — |
| Cash ConversionOCF / Net Profit; >1× = earnings back up with cash | 2.58× | 6.46× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period so offset fiscal years match up.
| Q4 25 | $294.1M | $471.7M | ||
| Q3 25 | $315.0M | $378.6M | ||
| Q2 25 | $363.5M | $475.3M | ||
| Q1 25 | $279.4M | $321.1M | ||
| Q4 24 | $283.5M | $373.6M | ||
| Q3 24 | $318.2M | $353.7M | ||
| Q2 24 | $316.2M | $335.9M | ||
| Q1 24 | $152.6M | $266.4M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $96.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 8.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 14.2% |
| Q4 25 | 2.58× | 6.46× | ||
| Q3 25 | — | 5.51× | ||
| Q2 25 | 11.48× | 6.65× | ||
| Q1 25 | 6.52× | 6.64× | ||
| Q4 24 | 62.36× | 6.36× | ||
| Q3 24 | 3.71× | 16.84× | ||
| Q2 24 | 2.17× | 15.87× | ||
| Q1 24 | 22.85× | — |
Financial Flow Comparison
Sankey diagram of revenue → gross profit → operating profit → net profit for each company. Charts shown full-width and stacked so both segment hierarchies are readable side-by-side on desktop and mobile.
